Not logged inGenetic and immune landscape evolution in MMR-deficient colorectal cancer
Challoner, Benjamin R.; Woolston, Andrew; Lau, David; Buzzetti, Marta; Fong, Caroline; Barber, Louise J.; Anandappa, Gayathri; Crux, Richard; Assiotis, Ioannis; Fenwick, Kerry; Begum, Ruwaida; Begum, Dipa; Lund, Tom; Sivamanoharan, Nanna; Sansano, Harold B.; Domingo-Arada, Melissa; Tran, Amina; Pandha, Hardev; Church, David; Eccles, Bryony; Ellis, Richard; Falk, Stephen; Hill, Mark; Krell, Daniel; Murugaesu, Nirupa; Nolan, Luke; Potter, Vanessa; Saunders, Mark; Shiu, Kai-Keen; Guettler, Sebastian; Alexander, James L.; Lazare-Iglesias, Hector; Kinross, James; Murphy, Jamie; von Loga, Katharina; Cunningham, David; Chau, Ian; Starling, Naureen; Ruiz-Banobre, Juan; Dhillon, Tony; Gerlinger, Marco .png)
Share.png)
SaveImpact of pharmacogenomic DPYD variant guided dosing on toxicity in patients receiving fluoropyrimidines for gastrointestinal cancers in a high-volume tertiary centreLau, David K.; Fong, Caroline; Arouri, Faten; Cortez, Lillian; Katifi, Hannah; Gonzalez-Exposito, Reyes; Razzaq, Muhammad Bilal; Li, Su; Macklin-Doherty, Aislinn; Hernandez, Monica Arenas; Hubank, Michael; Fribbens, Charlotte; Watkins, David; Rao, Sheela; Chau, Ian; Cunningham, David; Starling, Naureen Share Save Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trialsLedenko, Matthew; Antwi, Samuel O.; Arima, Shiho; Driscoll, Julia; Furuse, Junji; Klumpen, Heinz-Josef; Larsen, Finn Ole; Lau, David K.; Maderer, Annett; Markussen, Alice; Moehler, Markus; Nooijen, Lynn E.; Shaib, Walid L.; Tebbutt, Niall C.; Andre, Thierry; Ueno, Makoto; Woodford, Rachel; Yoo, Changhoon; Zalupski, Mark M.; Patel, Tushar Share Save Genetic and immune landscape evolution defines subtypes of MMR deficient colorectal cancerChalloner, Benjamin R.; Woolston, Andrew; Lau, David; Buzzetti, Marta; Barber, Louise J.; Lund, Tom; Sansano, Harold B.; von Loga, Katharina; Lazare-Iglesias, Hector; Begum, Ruwaida; Crux, Richard; Cunningham, David; Chau, Ian; Starling, Naureen; Ruiz-Banobre, Juan; Dhillon, Tony; Gerlinger, Marco Share Save Genetic and immune landscape evolution defines subtypes of MMR deficient colorectal cancerChalloner, Benjamin R.; Woolston, Andrew; Lau, David; Buzzetti, Marta; Barber, Louise J.; Lund, Tom; Sansano, Harold B.; von Loga, Katharina; Lazare-Iglesias, Hector; Begum, Ruwaida; Crux, Richard; Cunningham, David; Chau, Ian; Starling, Naureen; Ruiz-Banobre, Juan; Dhillon, Tony; Gerlinger, Marco Share Save Routine DPYD mutation testing for patients receiving fluoropyrimidines for gastrointestinal (GI) cancers: Real world experience in a tertiary UK oncology centreLau, D. K. W.; Fong, C.; Arouri, F.; Cortez, L.; Katifi, H.; Gonzalez-Exposito, R.; Razzaq, M. B.; Li, S.; Macklin-Doherty, A.; Fribbens, C.; Watkins, D.; Rao, S.; Chau, I.; Cunningham, D.; Starling, N. Share Save Rapid Resistance of FGFR-driven Gastric Cancers to Regorafenib and Targeted FGFR Inhibitors can be Overcome by Parallel Inhibition of MEKLau, David K.; Luk, Ian Y.; Jenkins, Laura J.; Martin, Andrew; Williams, David S.; Schoffer, Kael L.; Chionh, Fiona; Buchert, Michael; Sjoquist, Katrin; Boussioutas, Alex; Hayes, Sarah A.; Ernst, Matthias; Weickhardt, Andrew J.; Pavlakis, Nick; Tebbutt, Niall C.; Mariadason, John M. Share Save Share Save Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised studyLau, David; Kalaitzaki, Eleftheria; Church, David N.; Pandha, Hardev; Tomlinson, Ian; Annels, Nicola; Gerlinger, Marco; Sclafani, Francesco; Smith, Gillian; Begum, Ruwaida; Crux, Richard; Gillbanks, Angela; Wordsworth, Sarah; Chau, Ian; Starling, Naureen; Cunningham, David; Dhillon, Tony Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
